tiprankstipranks
TipRanksTop Financial ExpertsInsidersInvus Public Equities, Lp

Invus Public Equities, Lp Insider Profile

11 Followers
Invus Public Equities, Lp, Director, Ten Percent Owner at Lexicon Pharmaceuticals, holds 9.25M shares in Scholar Rock Holding (Ticker: SRRK), holds 6.32M shares in GlycoMimetics (Ticker: GLYC), holds 2.27M shares in Omega Therapeutics (Ticker: OMGA). Most recently, Invus Public Equities, Lp Sold ― shares of Scholar Rock Holding on Dec 12, 2024 for an estimated value of 66.64M.
tipranks
Invus Public Equities, Lp

Invus Public Equities, Lp
Lexicon Pharmaceuticals (LXRX)
Director, Ten Percent Owner

Ranked #41,514 out of 99,797 Corporate Insiders

Profitable Transactions

40%
12 out of 30 Profitable Transactions

Average Return

+0.40%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$476M
81.01%
12.30%
2.89%
2.29%
1.51% Others
A breakdown of Invus Public Equities, Lp's holdings

Insider Roles

Scholar Rock Holding
(SRRK)
Ten Percent Owner
Lexicon Pharmaceuticals
(LXRX)
Director, Ten Percent Owner
Seer
(SEER)
Ten Percent Owner
Agenus
(AGEN)
Ten Percent Owner
+4 other positions
Roles that Invus Public Equities, Lp holds in companies

Most Profitable Insider Trade

Stock:
Scholar Rock Holding
(SRRK)
Rating:Informative Buy
Date:Oct 16, 2023 - Oct 16, 2024
Return:+251.00%
The most profitable trade made by Invus Public Equities, Lp

Invus Public Equities, Lp's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Lexicon Pharmaceuticals
Dec 17, 2020
Director, Ten Percent Owner
Informative Buy
35.00M
$58.51M
Generation Bio
Jun 18, 2020
Ten Percent Owner
Informative Buy
15.20M
$3.35M
SQZ Biotechnologies
Nov 03, 2020
Ten Percent Owner
Informative Buy
7.44M
$43.37K
Seer
Feb 03, 2021
Ten Percent Owner
Informative Sell
16.20M
$13.75M
Omega Therapeutics
Aug 03, 2021
Ten Percent Owner
Uninformative Buy
$2.21M
Scholar Rock Holding
Dec 12, 2024
Ten Percent Owner
Informative Sell
66.64M
$385.26M
GlycoMimetics
Aug 09, 2024
Ten Percent Owner
Informative Sell
60.63K
$1.55M
Agenus
Ten Percent Owner
$10.88M
FURX
Furiex Pharmaceuticals
Feb 19, 2013
Informative Buy
List of latest transactions for each holding click on a transaction to see Invus Public Equities, Lp's performance on stock

Invus Public Equities, Lp insider profile FAQ

What is the percentage of profitable transactions made by Invus Public Equities, Lp?
The percentage of profitable transactions made by Invus Public Equities, Lp is 40%.
    What is the average return per transaction made by Invus Public Equities, Lp?
    The average return per transaction made by Invus Public Equities, Lp is 0.40%.
      What stocks does Invus Public Equities, Lp hold?
      Invus Public Equities, Lp holds: LXRX, GBIO, SQZB, SEER, OMGA, SRRK, GLYC, AGEN, FURX stocks.
        What was Invus Public Equities, Lp’s latest transaction?
        Invus Public Equities, Lp latest transaction was an Informative Sell of $66.64M.
          What was Invus Public Equities, Lp's most profitable transaction?
          Invus Public Equities, Lp’s most profitable transaction was an Informative Buy of SRRK stock on October 16, 2023. The return on the trade was 251.00%.
            What is Invus Public Equities, Lp's role in Lexicon Pharmaceuticals?
            Invus Public Equities, Lp's role in Lexicon Pharmaceuticals is Director, Ten Percent Owner.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.